Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Corus Pharma

Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.

Acquired by Gilead Sciences on October 22, 2006

Website: https://www.coruspharma.com

Founded: January 01, 2001

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
NarcX	Pharmaceuticals & Biotechnology	Be Part of the Solution - NarcX is the only solution that destroys and dispo ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
Apr 13, 2004	Series C	$ 65,000,000	Hambrecht & Quist Capital Management RBC Capital Markets Bear Stearns Health Innoventures L.P Novo A/S Integra Ventures OrbiMed Carnegie MPM Capital WestRiver Capital Washington State University Research Foundation SunAmerica Ventures Pacific Rim Ventures MDS Capital
Mar 07, 2003	Series B	$ 40,000,000	RBC Capital Markets Novo A/S MDS Capital Integra Ventures
Oct 03, 2002	Grant	$ 1,700,000	Cystic Fibrosis Foundation

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
There are no team members.